Genus Fda News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Genus Fda. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Genus Fda Today - Breaking & Trending Today

Agenus: FDA Grants Fast Track Designation For Botensilimab And Balstilimab In Colorectal Cancer

Published: April 17, 2023

Clinical-stage immuno-oncology company Agenus Inc. (GEN) Monday said the US Food and Drug Administration has granted Fast Track Designation for the investigation of the combination of botensilimab (AGEN1181) and balstilimab (AGEN2034).

Source: rttnews.com

Related Topics:

More Such Health NewsDrug AdministrationAgenus IncFast Track DesignationChief Medical OfficerFast TrackPriority ReviewColorectal CancerFast Track DesignationGenus Fda